Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
07/08/2026 05:07
BRIEF-Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth Aug 7 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU:
HUNGARY’S RICHTER: H1 EBIT 143.5 HUF BILLION
RICHTER -H1 REVENUES HUF 461.6 BILLION
RICHTER -H1 PHARMA REVENUES HUF 455.2 BILLION
HUNGARY’S RICHTER: UPGRADES 2026 PHARMA CLEAN EBIT GUIDANCE TO DOUBLE-DIGIT GROWTH
Source text: [ID:]
Further company coverage: GDRB.BU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection